Use of PDE III Inhibitors for the treatment of asymptomatic Cardiac isuficiencia (hidden)

摘要

1. Prepare the drug with a third phosphate inhibitor (pdeii) or a second + sensitizer or acceptable pharmaceutical derivative to extend the time for patients with or with chemical weapons to begin clinical symptomsA silent (recessive) heart failure reduces heart failure in patients with silent (recessive) or silent heart disease. Requirement 4: use 1-3 as requiredAmong them, PDE III inhibitors or Ca2 + sensitizers are selected from the following groups: pimobendan, milrinona, levosimendan, amrinona, enoxomona and piroximona, or their acceptable pharmaceutical derivatives.